We developed a GAPDH aggregation inhibitor (GAI) peptide.
The GAI peptide inhibits GAPDH aggregation in a concentration-dependent manner.
The GAI peptide does not affect GAPDH enzyme activity or cell viability.
The GAI peptide shows a protective effect against oxidative stress-induced cell death.
We produced a novel tool to study oxidative stress-induced disorders.